OpenRegistry
UK companies/Company owner profile

CANCER RESEARCH TECHNOLOGY LIMITED

UK registered
openregistry-gb-01626049·27 UK shareholdings·2 ownership layers

CANCER RESEARCH TECHNOLOGY LIMITED is a UK-registered corporate shareholder (Companies House number 01626049) and holds shares in 27 active UK companies, recorded across 30 share-class positions on their Companies House confirmation statements (CS01). Beneath those direct holdings OpenRegistry resolves a further 1 companies spanning 2 ownership layers, of which 1 direct holdings are themselves holding companies; the persons-with-significant-control register independently agrees on 1 of these holdings. Sophymarine OpenRegistry ID openregistry-gb-01626049. It ranks #225 of 54,210 corporate shareholders by number of active UK holdings. Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Companies held
27
Share-class positions
30
Identity
UK company 01626049
Jurisdiction
UNITED KINGDOM
Ownership layers below
2
Holdings that are holding companies
1
PSC register agrees on
1 holdings

Company profile

Companies House profile of CANCER RESEARCH TECHNOLOGY LIMITED

Shareholders

Shares held by CANCER RESEARCH TECHNOLOGY LIMITED in 27 UK companies

Ownership chain

1 companies across 2 layers beneath CANCER RESEARCH TECHNOLOGY LIMITED

Official record

Companies House record 01626049

Shareholdings

Every company CANCER RESEARCH TECHNOLOGY LIMITED appears on as a member, as filed. 27 of 27 are linked to their Companies House profile.

Company heldStatusAccountsShare classShares% of class% of capitalTotal % of capitalAs of
STRATOSVIR LIMITEDopenregistry-gb-13099988ActiveTOTAL EXEMPTION FULLORDINARY16,98412.73%12.73%12.73%2025-12-24
ZYGOSITY LIMITEDopenregistry-gb-12760444ActiveTOTAL EXEMPTION FULLORDINARY157,89510.94%10.94%10.94%2023-07-21
CELLINTA LTDopenregistry-gb-12161294ActiveMICRO ENTITYORDINARY714,2868.48%8.48%8.48%2022-11-28
NK:IO LTDopenregistry-gb-12479455ActiveTOTAL EXEMPTION FULLSEED289,01714.88%7.89%7.89%2024-03-20
VERINNOGEN LIMITEDopenregistry-gb-13266666ActiveTOTAL EXEMPTION FULLORDINARY A165,79014.76%7.44%7.44%2026-03-14
52 NORTH HEALTH LTDopenregistry-gb-11460425ActiveTOTAL EXEMPTION FULLSERIES SEED12,15012.88%4.46%4.46%2026-02-21
MOSAIC THERAPEUTICS LIMITEDopenregistry-gb-12780154ActiveSMALLSERIES A2 PREFERRED1,303,2902.75%2.09%2.09%2025-07-29
NUCLEARMEDIX LIMITEDopenregistry-gb-16134861ActiveNO ACCOUNTS FILEDT ORDINARY SHARES1,09021.80%1.09%1.09%2025-12-12
BIOCAPTIVA LIMITEDopenregistry-gb-SC609101ActiveSMALLORDINARY £0.000114,7500.81%0.81%0.81%2025-09-05
GENOME THERAPEUTICS LTDopenregistry-gb-12392992ActiveSMALLORDINARY10,0001.33%0.51%0.51%2026-01-07
CYTED LTDopenregistry-gb-11478299ActiveGROUPORDINARY27,7072.69%0.44%0.44%2025-07-22
SIFTR BIO LIMITEDopenregistry-gb-15665818ActiveMICRO ENTITYT ORDINARY3,9605.85%0.29%0.29%2025-04-21
AKAMIS BIO LIMITED ▼openregistry-gb-06001442ActiveGROUPORDINARY00.00%0.00%2026-02-02
INFINITOPES LIMITEDopenregistry-gb-13642685ActiveTOTAL EXEMPTION FULLORDINARY619,4112024-09-23
SEED121,951
TROGENIX LTDopenregistry-gb-14930146ActiveTOTAL EXEMPTION FULLSEED3,5002024-06-11
OLIGOTUNE LTDopenregistry-gb-15373740ActiveTOTAL EXEMPTION FULLORDINARY21,3642026-04-25
SPLICEOR LTDopenregistry-gb-12826144ActiveTOTAL EXEMPTION FULLORDINARY. 0.000001 GBP25,1062025-08-19
STORM THERAPEUTICS LIMITEDopenregistry-gb-09553473ActiveGROUPORDINARY100,0002026-04-21
ARTIOS PHARMA LIMITEDopenregistry-gb-09931309ActiveGROUPORDINARY3,750,0002025-12-28
GAMMADELTA THERAPEUTICS LTDopenregistry-gb-10238425ActiveFULLORDINARY SHARES02023-06-16
EPSILOGEN LTDopenregistry-gb-10295520ActiveFULLORDINARY600,0002025-07-25
ELAITRA LTDopenregistry-gb-11317171ActiveMICRO ENTITYA ORDINARY69,0682026-04-24
MYRICX PHARMA LIMITEDopenregistry-gb-12082645ActiveSMALLSERIES A SHARES513,7872025-07-02
T ORDINARY13,628
MISSION THERAPEUTICS LIMITEDopenregistry-gb-07630933ActiveFULLORDINARY283,5002025-05-11
MANTRA DIAGNOSTICS LIMITEDopenregistry-gb-13040292ActiveMICRO ENTITYORDINARY1,3202021-11-23
NEOBE THERAPEUTICS LTDopenregistry-gb-13146056ActiveTOTAL EXEMPTION FULLA ORDINARY 0.001 GBP8,6962026-01-20
ORDINARY 0.001 GBP13,535
ENEDRA THERAPEUTICS LIMITEDopenregistry-gb-13433538ActiveTOTAL EXEMPTION FULLORDINARY16,8422025-06-01

Ownership structure below these holdings

1 further companies sit beneath this entity’s direct holdings, across 2 layers. Each is linked to its Companies House profile.

Related company owners

Corporate shareholders that hold shares in the same UK companies as CANCER RESEARCH TECHNOLOGY LIMITED:

Other corporate shareholders of comparable size registered in UNITED KINGDOM:

Need the registered office, SIC code, accounts and filing history for CANCER RESEARCH TECHNOLOGY LIMITED? Open its Companies House profile at https://openregistry.sophymarine.com/insights/gb/01626049-cancer-research-technology-limited.

▼ marks a holding that itself holds shares in further companies, so ownership continues below it.

“% of capital” is the entity’s share of issued capital by nominal value, the correct basis when a company has multiple share classes.

Figures are as filed on each company’s most recent confirmation statement; the “As of” column gives that statement date. Source: Companies House Free Company Data and CS01 confirmation statements. Official record: find-and-update.company-information.service.gov.uk.